Туберкульоз. Адаптована клінічна настанова, заснована на доказах (стр. 108 )

97.  Ormerod LP, Bentley C. The management of lymph node tuberculosis notified in England and Wales in 1993. Journal of the Royal College of Physicians of London 1997;31{6):666-668.

98.  Ormerod LP, Bentley C. The management of pulmonary tuberculosis notified in England and Wales in 1993. Journal of the Royal College of Physicians of London 1997;31(6):662-665.

99.  Mitchison DA, Nunn AJ, Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. American Review of Respiratory Disease 1986;133(3):423-430.

100. Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens. Morbidity & Mortality Weekly Reporl20Q2;5l(lQ):2\4-2\5.

101. Jindani A, Aber VR, Edwards EA, Mitchison DA. The early bactericidal activity of drugs in patients with pulmonary tuberculosis, American Review of Respiratory Disease 1980;121{6):939-949.

102. Rouillon A, Perdrizet S, Parrot R. Transmission of tubercle bacilli: the effects of chemotherapy. Tubercle 1976;57(4):275-299.

103. Tokars JI, McKinley GF, Otten J, Woodley C et al. Use and efficacy of tuberculosis infection control practices at hospitals with previous outbreaks of multidrug-resistant tuberculosis. Infection Control & Hospital Epidemiology 2001 ;22(7):449-455.

104. Health and Safety Executive, Respiratory protective equipment at work: a practical guide. London: HSE} 2005.

105. NHS Estates. Isolation facilities in acute settings: in patient accommodation: options for choice. Health Building Notes 4 supplement 1, London, 2005.

106. Wallgren A. The timetable of tuberculosis, Tubercle 1948;29:245-251.

107. Ormerod LP, Horsfield N. Miliary tuberculosis in a high prevalence area of the United Kingdom. Blackburn 1978-93, Respiratory Medicine 1995;89(8):555-557.

108. MRC Streptomycin in Tuberculosis Trials Committee. Streptomycin treatment in tuberculous meningitis. Lancet 1947;1:582-597.

109. Teoh R, Humphries MI, O'Mahoney G, Symptomatic intracranial tuberculoma developing during treatment of tuberculosis: a report of 10 cases and a review of the literature. Quarterly Journal of Medicine 1987;63(241):449~460.

110. Martineau All, Lowey H, Tocque K, Davies PD. Decreasing tuberculosis case fatality in England and Wales, 1988-2001. International Journal of Tuberculosis & Lung Disease 2004;8(6):737-742.

111. Doganay M, Calangu S, Turgut H, Bakir M, Aygen B. Treatment of tuberculous meningitis in Turkey. Scandinavian Journal of Infectious Diseases 1995;27(2):135-138,

112. Short-course chemotherapy for tuberculous meningitis. 89 A. D. Oct 22; the XlVth World Congress of Neurology. 1990,

113. Chotmongkol V. Treatment of tuberculous meningitis with 6-month course of chemotherapy. Southeast Asian Journal of Tropical Medicine & Public Health 1991;22(3):372-374.

114. Alarcon F, Escalante L, Perez Y, Banda Wet al. Tuberculous meningitis: short course of chemotherapy. Archives of Neurology 1990;47(12):1313-1317.

115. Acharya VN, Kudva BT, Retnam VJ, Mehta PJ. Adult tuberculous meningitis: comparative study of different chemotherapeutic regimens. Journal of the Association of Physicians of India 1985;33(9):583-585.

116. Loenhout-Rooyackers JH, Keyser A, Laheij RJ, Verbeek AL, van der Meer JW. Tuberculous meningitis: is a 6-month treatment regimen sufficient? International Journal of Tuberculosis & Lung Disease 2001; 5(11): 1028-1035.

117. Jacobs RF, Sunakorn P, Chotpitayasunonah T, Pope S, Kelleher K, Intensive short course chemotherapy for tuberculous meningitis. Pediatric Infectious Disease Journal 1992;11(3);194-198.

118. Donald PR, Schoeman JF, Van Zyl LE, De Villiers JN et al. Intensive short course chemotherapy in the management of tuberculous meningitis. International Journal of Tuberculosis & Lung Disease 1998; 2{9):704-711.

119. Phuapradit P, Vejjajiva A. Treatment of tuberculous meningitis: role of short-course chemotherapy. Quarterly Journal of Medicine 1987;62(239):249-258.

120. Goel A, Pandya SK, Satoskar AR. Whither short-course chemotherapy for tuberculous meningitis? Neurosurgery 1990;27(3):418-421.

121. Humphries MJ, Teoh R, Lau }, Gabriel M. Factors of prognostic significance in Chinese children with tuberculous meningitis. Tubercle 1990;71(3):161-168.

122. Ramachandran P, Duraipandian M, Nagarajan M, Prabhakar R et al. Three chemotherapy studies of tuberculous meningitis in children. Tubercle 1986;67(l):17-29,

123. Ramachandran P, Duraipandian M, Reetha AM, Mahalakshmi SM, Prabhakar R, Long-term status of children treated for tuberculous meningitis in south India. Tubercle 1989;70(4):235~239.

124. Prasad K, Volmink J, Menon GR. Steroids for treating tuberculous meningitis. The Cochrane Library 2000;(3):CD002244.

125. O'Toole RD, Thornton GF, Mukherjee MK, Nath RL. Dexamethasone in tuberculous meningitis: relationship of cerebrospinal fluid effects to therapeutic efficacy. Annals of Internal Medicine 1969; 70(1):39~48.

126. Girgis NI, Farid Z, Kilpatrick ME, Sultan Y, Mikhail IA. Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatric Infectious Disease Journal 1991;10(3):179-183,

127. Kumarvelu S, Prasad K, Khosla A, Behari M, Ahuja GK. Randomized controlled trial of dexamethasone in tuberculous meningitis. Tubercle & Lung Disease 1994;75(3);203-207,

128. Chotmongkol V, Jitpimolmard S, Thavompitak Y. Corticosteroid in tuberculous meningitis. Journal of the Medical Association of Thailand 1996;79(2):83~90.

129. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics 1997;99(2):226-231.

130. Lardizabal DV, Roxas AA. Dexamethasone as adjunctive therapy in adult patients with probable tuberculous meningitis stage II and IH: an open randomized controlled trial. The Philippine Journal of Neurology 1998;4:2-11.

131. Dooley DP, Carpenter JL, Rademacher S. Adjunctive corticosteroid therapy for tuberculosis; a critical reappraisal of the literature. Clinical Infectious Diseases 1997;25(4):872~-887,

132. Thwaites GE, Nguyen HD, Hoang TQ, Do TT, Nguyen TC. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. New England Journal of Medicine 2004;351(17): 1741-1751.

133. Ormerod LP. Tuberculosis in pregnancy and the puerperium. 77iorax2001;56(6):494-499.

134. Campbell IA, Dyson AJ. Lymph node tuberculosis: a comparison of various methods of treatment. Tubercle I977;58(4):171-I79.

135. British Thoracic Society Research Committee. Short course chemotherapy for tuberculosis of lymph nodes: a controlled trial. British Medical journal (Clinical researched) 1985;290{6475):1106-1108.

136. British Thoracic Society Research Committee. Six-months versus nine-months chemotherapy for tuberculosis of lymph nodes: preliminary results. Respiratory Medicine 1992;86(1):15~19,

137. Campbell IA, Ormerod LP, Friend JA, Jenkins PA, Prescott RJ. Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results. Respiratory Medicine 1993;87(8):621-623,

138. Loenhout-Rooyackers JH, Laheij RJ, Richter C, Verbeek AL Shortening the duration of treatment for cervical tuberculous lymphadenitis. European Respiratory Journal 200Q;lS(l}:\92--\95,

139. Yuen AP, Wong SH, Tarn CM, Chan SL et al Prospective randomized study of thrice weekly six-month and nine-month chemotherapy for cervical tuberculous lymphadenopathy. Otolaryngology - Head & Neck Surgery 1997;! 16(2):189-192.

140. Tuberculosis Section; Health Protection Agency Centre for Infections. Annual report on tuberculosis cases reported in 2002 in England, Wales and Northern Ireland: enhanced tuberculosis surveillance. London; Health Protection Agency, 2005.

141. Upadhyay SS, Saji MJ, Yau AC. Duration of antituberculosis chemotherapy in conjunction with radical surgery in the management of spinal tuberculosis. Spine 1996;21(16):1898-1903.

142. Medical Research Council Working Party on tuberculosis of the spine Five-year assessment of controlled trials of short-course chemotherapy regimens of 6, 9 or 18 months' duration for spinal tuberculosis in patients ambulatory from the start or undergoing radical surgery. International Orthopaedics 1999;23(2):73-81.

143. Parthasarathy R, Sriram K, Santha T, Prabhakar R et al Short-course chemotherapy for tuberculosis of the spine: a comparison between ambulant treatment and radical surgery - ten-year report. Journal of Bone & Joint Surgery British Volume 1999;81B(3):464-471,

144. Medical Research Council Working Party on Tuberculosis of the Spine. A controlled trial of ambulant outpatient treatment and in-patient rest in bed in the management of tuberculosis of the spine in young Korean patients on standard chemotherapy. Journal of Hone & Joint Surgery British Volume 1973;55B{4): 678-697.

145. Medical Research Council Working Party on Tuberculosis of the Spine, A 5-year assessment of controlled trials of inpatient and outpatient treatment and of plaster-of-paris jackets for tuberculosis of the spine in children on standard chemotherapy. Journal of Bone & Joint Surgery British Volume 1976;58B{4): 399-411.

146. Medical Research Council Working Party on Tuberculosis of the Spine. A controlled trial of plaster-of-paris jackets in the management of ambulatory outpatient treatment of tuberculosis of the spine in children on standard chemotherapy: a study in Pusan, Korea. Tubercle 1973;54(4):261-282.

147. Medical Research Council Working Party, A controlled trial of debridement and ambulatory treatment in the management of tuberculosis of the spine in patients on standard chemotherapy,- a study in Bulawayo, Rhodesia. Journal of Tropical Medicine & Hygiene 1974;77(4):72—92,